{"text": "also of note, validates ceo anzalone's depiction of fast moving pre-clinical work delineates $amgn collaboration w/\u00a1\u00ad URL"}
{"text": "fy2018 eps estimates for amgen, inc. decreased by william blair $amgn URL"}
{"text": "fy2018 eps estimates for amgen, inc. decreased by william blair $amgn URL"}
{"text": "william blair lowers amgen fy2018 earnings estimates to $12.13 per share (previously $12.39). $amgn URL #amgn"}
{"text": "vp r&amp;d sean harper plural &amp; subtle mention (targets) i.e. ~future collab w/ $arwr during $amgn 4/26 cc AT_USER URL"}
{"text": "amgen, inc. $amgn given buy rating at cowen and company URL"}
{"text": "amgen, inc. $amgn given buy rating at cowen and company URL"}
{"text": "$amgn execs don't want you to think low enbrel sales in q1 are indicative of a trend #icymi URL"}
{"text": "rt AT_USER balanced take on rnai approach in current drug development landscape by $amgn's sean harper, this should also apply to $md\u00a1\u00ad"}
{"text": "snippets roundup: sanofi diabetes disappointment, and amgen pullback signals cgrp caution URL $sny $amgn $nonof $mdco"}
{"text": "snippets roundup: sanofi diabetes disappointment, and amgen pullback signals cgrp caution URL $sny $amgn $nonof $mdco"}
{"text": "amgen, inc. $amgn updates fy17 earnings guidance URL"}
{"text": "rt AT_USER members watch list almost done focus next week on drugs and health care $amgn, $gild also see these special alerts htt\u00a1\u00ad"}
{"text": "members watch list almost done focus next week on drugs and health care $amgn, $gild also see these special alerts\u00a1\u00ad URL"}
{"text": "gabelli lowers amgen fy2017 earnings estimates to $12.10 per share (previously $12.40). $amgn URL #amgn"}
{"text": "fy2017 earnings estimate for amgen, inc. $amgn issued by gabelli URL"}
{"text": "how low can you go? u.s. pharma already shoulders light tax burden URL $amgn $celg $biib $abbv $pfe $shpg $agn $jnj"}
{"text": "how low can you go? u.s. pharma already shoulders light tax burden URL $amgn $celg $biib $abbv $pfe $shpg $agn $jnj"}
{"text": "$amgn sum put vol=364 sum call vol=1,877 putcallratio=0.19 expiration 05/05/2017 . URL URL"}
{"text": "7drugmakers relied on price hikes for 100% of their earnings rise URL $amgn $lly $abbv $mrk $pfe URL"}
{"text": "radius nabs fda ok for new bone drug with rival #amgen close behind. read more: URL $amgn"}
{"text": "$amgn a few headwinds,, take advantage of the coming pullback it could downtrend for next 45+/- days  imo,,channel  135ish to 175+/-"}
{"text": "radius nabs fda ok for new bone drug with rival amgen close behind URL $rdus $amgn $lly"}
{"text": "rt AT_USER $sny $regn q1 praluent sales were approximately $37m. which compares to $49m for $amgn's repatha. URL h\u00a1\u00ad"}
{"text": "amgen, inc. $amgn updates fy17 earnings guidance URL"}
{"text": "amgen, inc. $amgn updates fy17 earnings guidance URL"}
{"text": "research analysts set expectations for amgen, inc.\u00a1\u00afs q3 2017 earnings $amgn URL"}
{"text": "leerink swann lowers amgen q3 2017 earnings estimates to $3.13 per share (previously $3.17). $amgn URL #amgn"}
{"text": "$amgn r.w. baird reiterates neutral rating, $165 pt URL"}
{"text": "amgen, inc. $amgn stock rating reaffirmed by robert w. baird URL #stocks"}
{"text": "amgen, inc. $amgn stock rating reaffirmed by robert w. baird URL"}
{"text": "amgen's neutral rating reiterated at robert w. baird. $165.00 pt. URL $amgn #amgn"}
{"text": "as widely expected, $rdus wins fda approval for tymlos (abaloparatide); going up against forteo and \u00a8c possibly \u00a8c a $amgn\u00a1\u00afs romosozumab"}
{"text": "amgen, inc. $amgn earns market perform rating from sanford c. bernstein URL"}
{"text": "amgen, inc. $amgn earns market perform rating from sanford c. bernstein URL"}
{"text": "$rdus $amgn $lly  this will be a 3 horse race: tymlos, romo, and generic forteo URL"}
{"text": "sad liquidation day. $vrx $agn $myl $brk  $iep $ko $pep $hlf $cmg $msft $fb $tsla $wfc $jpm $bac $tst $jazz $flxn\u00a1\u00ad URL"}
{"text": "rt AT_USER bmt/dmhc #acc17 some large payers do not need chart documentation already in pa but mds may not be aware $amgn $regn URL"}
{"text": "rt AT_USER bmt/dmhc #acc17 md demand to increase some even with current pa, but payers unlikely to change pa much $amgn $regn URL"}
{"text": "rt AT_USER bmt/dmhc #acc17 report-results from payer interviews and md survey on pcsk9 URL $amgn $regn"}
{"text": "bmt/dmhc #acc17 some large payers do not need chart documentation already in pa but mds may not be aware $amgn $regn URL"}
{"text": "biotech surge: how to survive in a volatile market $amgn $espr $regn $mdco $ibb $xbi $gild $celg $biib $incy $tsro URL"}
{"text": "bmt/dmhc #acc17 md demand to increase some even with current pa, but payers unlikely to change pa much $amgn $regn URL"}
{"text": "bmt/dmhc #acc17 report-results from payer interviews and md survey on pcsk9 URL $amgn $regn"}
{"text": "for large cap bio, i like $gild and $amgn for the $ &amp; bod. like $regn and $shpg for revs, pipe, and ability to consolidate."}
{"text": "q2 2017 eps estimates for amgen, inc. raised by analyst $amgn URL"}
{"text": "i need a job asap! hire me! $vrx $teva $agn $myl $ko $brk $hlf $iep $amgn $jnj $amzn $mrk $bac $hd $shak $msft $goog $twtr $tst $pypl $aapl"}
{"text": "these 7 drugmakers relied on price hikes for 100% of their earnings growth in 2016 URL $amgn $biib $agn $pfe $lly $mrk"}
{"text": "why biotech giant #amgen's q1 results indicate the need for an m&amp;a  . read more: URL $amgn"}
{"text": "amgen, inc. $amgn releases quarterly earnings results, beats estimates by $0.15 eps URL"}
{"text": "$amgn oi for maturity 05/05/2017. 160.00 highest put. 165.00 highest call. URL URL"}
{"text": "rt AT_USER $sny $regn q1 praluent sales were approximately $37m. which compares to $49m for $amgn's repatha. URL h\u00a1\u00ad"}
{"text": "AT_USER AT_USER AT_USER AT_USER $amgn declining revenue as well. but seeing money flow into $exas\u00a1\u00ad URL"}
{"text": "rt AT_USER amgen, inc. $amgn short interest down 12.3% in april URL"}
{"text": "amgen, inc. $amgn short interest down 12.3% in april URL #acn"}
{"text": "amgen, inc. $amgn short interest down 12.3% in april URL"}
{"text": "#amgen reports -st-quarter earnings results. read more: URL $amgn"}
{"text": "amgen, inc. $amgn short interest down 12.3% in april URL"}
{"text": "fenimore asset management inc. takes position in amgen, inc. $amgn URL"}
{"text": "fenimore asset management inc. takes position in amgen, inc. $amgn URL"}
{"text": "fenimore asset management inc. takes position in amgen, inc. $amgn URL"}
{"text": "carroll financial associates inc. has $1.298 million position in amgen, inc. $amgn URL"}
{"text": "national pension service increases stake in amgen, inc. $amgn URL"}
{"text": "national pension service increases stake in amgen, inc. $amgn URL"}
{"text": "fenimore asset management inc. takes position in amgen, inc. $amgn URL #stocks"}
{"text": "stillwater investment management llc has $2.659 million stake in amgen, inc. $amgn URL"}
{"text": "stillwater investment management llc has $2.659 million stake in amgen, inc. $amgn URL"}
{"text": "#biotech  5 golden rules for better biotech investing URL $abbv $amgn $bdsi $ceru $ptla $rlyp"}
{"text": "$sny praluent cvot in 1q18 $amgn $regn"}
{"text": "amgen, inc. $amgn short interest down 12.3% in april URL #stocks"}
{"text": "amgen, inc. $amgn short interest down 12.3% in april URL"}
{"text": "amgen, inc. $amgn short interest down 12.3% in april URL"}
{"text": "amgen, inc. $amgn short interest down 12.3% in april URL"}
{"text": "rt AT_USER $sny $regn q1 praluent sales were approximately $37m. which compares to $49m for $amgn's repatha. URL h\u00a1\u00ad"}
{"text": "rt AT_USER $sny $regn q1 praluent sales were approximately $37m. which compares to $49m for $amgn's repatha. URL h\u00a1\u00ad"}
{"text": "$sny $regn q1 praluent sales were approximately $37m. which compares to $49m for $amgn's repatha.\u00a1\u00ad URL"}
{"text": "#amgen's new cholesterol drug falls short as sales driver. read more: URL $amgn"}
{"text": "rt AT_USER #pharma companies battle for slice of humira's billions. #fda #biosimilars $abbv $amgn $celg $jnj URL URL"}
{"text": "rt AT_USER analyst activity \u00a8c cowen and company reiterates buy on amgen (nasdaq:amgn) URL $amgn"}
{"text": "rt AT_USER analyst activity \u00a8c cowen and company reiterates buy on amgen (nasdaq:amgn) URL $amgn"}
{"text": "analyst activity \u00a8c cowen and company reiterates buy on amgen (nasdaq:amgn) URL $amgn"}
{"text": "$amgn cowen &amp; company reiterates buy rating, $209 pt URL"}
{"text": "rt AT_USER analyst activity \u00a8c cowen and company reiterates buy on amgen (nasdaq:amgn) URL $amgn"}
{"text": "rt AT_USER analyst activity \u00a8c cowen and company reiterates buy on amgen (nasdaq:amgn) URL $amgn"}
{"text": "analyst activity \u00a8c cowen and company reiterates buy on amgen (nasdaq:amgn) URL $amgn"}
{"text": "amgen, inc. $amgn rating reiterated by cowen and company URL"}
{"text": "amgen's buy rating reiterated at cowen and company. $209.00 pt. URL $amgn #amgn"}
{"text": "amgen, inc. $amgn releases fy17 earnings guidance URL"}
{"text": "$amgn max pain is 162.50 for maturity 05/05/2017. prev close = 164.61.  URL URL"}
{"text": "rt AT_USER will $amgn &amp; #sandoz court battle over 'patent-dance' when marketing a new #biosimilar drug set a new precedent? URL"}
